疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響_第1頁
疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響_第2頁
疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響_第3頁
疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響_第4頁
疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響_第5頁
已閱讀5頁,還剩4頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響摘要:

目的:研究疏風(fēng)醒鼻法治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)對血清IL-35、IL-37的影響。

方法:選擇2019年10月至2020年5月在本院住院治療的40例兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型)患兒作為研究對象,隨機(jī)分為治療組和對照組,每組各20例。對照組采用傳統(tǒng)的中藥、抗過敏藥物等治療方法,而治療組采用疏風(fēng)醒鼻法治療。通過觀察患兒的病情變化以及采集患者的血清樣本,比較兩組患兒治療前后血清IL-35、IL-37的水平變化。

結(jié)果:治療組治療后總有效率高于對照組(95%與75%),差異具有統(tǒng)計(jì)學(xué)意義(P<0.05)。治療后治療組患兒的鼻炎癥狀明顯改善,呼吸道癥狀減輕,對常見的過敏原具有更好的耐受性。治療組患兒血清IL-35、IL-37水平增加明顯,并且治療后血清IL-35、IL-37水平與對照組相比有顯著升高(P<0.05)。

結(jié)論:疏風(fēng)醒鼻法可以治療兒童變應(yīng)性鼻炎(風(fēng)邪犯肺型),能夠有效地改善患兒癥狀,并且具有調(diào)節(jié)機(jī)體免疫功能的作用,在治療過程中可以提高血清IL-35、IL-37水平。

關(guān)鍵詞:疏風(fēng)醒鼻法;兒童變應(yīng)性鼻炎;風(fēng)邪犯肺型;IL-35;IL-37

Abstract:

Objective:ToinvestigatetheeffectofShufengXingbitherapyonserumIL-35andIL-37inthetreatmentofchildrenwithallergicrhinitis(wind-heatinvadinglungtype).

Methods:Fortychildrenwithallergicrhinitis(wind-heatinvadinglungtype)whowerehospitalizedinourhospitalfromOctober2019toMay2020wereselectedastheresearchobjectsandrandomlydividedintoatreatmentgroupandacontrolgroup,with20casesineachgroup.ThecontrolgroupwastreatedwithtraditionalChinesemedicine,anti-allergicdrugs,andothertreatmentmethods,whilethetreatmentgroupwastreatedwithShufengXingbitherapy.Thechangesinthepatients'conditionwereobserved,andserumsampleswerecollectedtocomparethechangesinthelevelsofIL-35andIL-37inthetwogroupsofpatientsbeforeandaftertreatment.

Results:Thetotaleffectiverateofthetreatmentgroupwashigherthanthatofthecontrolgroupaftertreatment(95%and75%,respectively),andthedifferencewasstatisticallysignificant(P<0.05).Aftertreatment,thesymptomsofrhinitisinthetreatmentgroupweresignificantlyimproved,respiratorysymptomswerereduced,andtolerancetocommonallergenswasbetter.ThelevelsofIL-35andIL-37inthetreatmentgroupweresignificantlyincreasedaftertreatment,andthelevelsofIL-35andIL-37inthetreatmentgroupweresignificantlyhigherthanthoseinthecontrolgroup(P<0.05).

Conclusion:ShufengXingbitherapycaneffectivelytreatchildrenwithallergicrhinitis(wind-heatinvadinglungtype),improvetheirsymptoms,andregulatethebody'simmunefunction.Duringtreatment,thelevelsofserumIL-35andIL-37canbeincreased.

Keywords:ShufengXingbitherapy;allergicrhinitisinchildren;wind-heatinvadinglungtype;IL-35;IL-3Allergicrhinitisisacommondiseaseinchildrenthataffectstheirqualityoflife.Thetreatmentofallergicrhinitismainlyincludesdrugtherapyandimmunotherapy.ShufengXingbitherapyisatraditionalChinesemedicinetreatmentthatiseffectiveintreatingallergicrhinitis.ThecurrentstudyaimedtoevaluatetheefficacyofShufengXingbitherapyintreatingchildrenwithallergicrhinitis(wind-heatinvadinglungtype)andtoinvestigatethechangesinthelevelsofIL-35andIL-37duringtreatment.

TheresultsofthisstudyshowedthataftertreatmentwithShufengXingbitherapy,thetotaleffectiverateofclinicalsymptomswassignificantlyhigherthanthatofthecontrolgroup.Thenasalsymptomssuchasrunnynose,nasalcongestion,andsneezingweresignificantlyimprovedinthetreatmentgroupcomparedtothecontrolgroup.Additionally,theserumlevelsofIL-35andIL-37inthetreatmentgroupweresignificantlyhigherthanthoseinthecontrolgroup.ThismaysuggestthatShufengXingbitherapycanregulatethebody'simmunefunctionbyincreasingthelevelsoftheseanti-inflammatorycytokines.

Inconclusion,ShufengXingbitherapycanbeaneffectivetreatmentforchildrenwithallergicrhinitis(wind-heatinvadinglungtype).Thetherapycanimprovetheclinicalsymptomsandregulatetheimmunefunctionofthebody.ThelevelsofserumIL-35andIL-37canbeincreasedduringthetreatment,indicatingitspotentialmechanismofaction.FurtherstudieswithalargersamplesizeandlongertreatmentdurationareneededtoconfirmtheefficacyandsafetyofShufengXingbitherapyforallergicrhinitisinchildrenInadditiontoShufengXingbitherapy,thereareothertreatmentoptionsavailableforchildrenwithallergicrhinitis.Theseincludenasalcorticosteroids,antihistamines,decongestants,leukotrienereceptorantagonists,andimmunotherapy.

Nasalcorticosteroidsareeffectiveinreducingnasalcongestion,inflammation,andmucusproduction.Theyaresafeandwell-tolerated,butmaytakeseveraldaystostartworking.Somecommonnasalcorticosteroidsincludefluticasone,budesonide,andmometasone.

Antihistaminesaremedicationsthatblocktheeffectsofhistamine,achemicalreleasedbymastcellsduringanallergicreaction.Theycanrelievesneezing,itching,andrunnynose,butmaycausedrowsinessordrymouth.Commonantihistaminesusedinchildrenincludeloratadine,cetirizine,andfexofenadine.

Decongestantsaremedicationsthatshrinkswollenbloodvesselsinthenasalpassages,reducingcongestion.Theycanbetakenorallyorappliedtopicallyasnasalsprays,butshouldnotbeusedformorethanafewdaysduetoriskofreboundcongestion.Commondecongestantsincludepseudoephedrineandphenylephrine.

Leukotrienereceptorantagonistsaremedicationsthatblocktheeffectsofleukotrienes,substancesproducedbyimmunecellsthatpromoteinflammationandallergysymptoms.Theycanbeanalternativetoantihistaminesornasalcorticosteroids,butmaycausemoodchangesorliverproblems.Montelukastisacommonleukotrienereceptorantagonistusedinchildren.

Immunotherapy,alsoknownasallergyshots,isalong-termtreatmentthatinvolvesregularinjectionsofsmallamountsofallergenstodesensitizetheimmunesystem.Itcanreducetheseverityandfrequencyofallergicrhinitissymptoms,butrequiresacommitmentofseveralyearsandmaycauselocalreactionsoranaphylaxis.Immunotherapyisusuallyreservedforchildrenwithsevereorpersistentallergicrhinitisthatcannotbecontrolledwithothertreatments.

Inconclusion,allergicrhinitisisacommonconditionaffectingmanychildrenworldwide.Itcanhaveasignificantimpactonqualityoflifeandacademicperformance,andmayleadtocomplicationssuchassinusitisorasthma.TreatmentoptionsincludeShufengXingbitherapy,aswellasnasalcorticosteroids,antihistamines,decongestants,leukotrienereceptorantagonists,andimmunotherapy.Thechoiceoftreatmentshouldbebasedontheseverityanddurationofsymptoms,aswellasthepotentialbenefitsandrisksforeachindividualchild.FurtherresearchisneededtoimproveourunderstandingoftheunderlyingmechanismsandoptimalmanagementstrategiesforallergicrhinitisinchildrenInadditiontomedicaltreatment,therearealsonon-pharmacologicaloptionsthatcanhelpmanageallergicrhinitisinchildren.Theseinclude:

1.Allergenavoidance:Identifyingandavoidingtheallergensthattriggersymptomscanbehelpful.Commonallergensincludedustmites,animaldander,pollen,andmold.Measuressuchasusinghypoallergenicbedding,keepingpetsoutofthebedroom,andregularlycleaningandvacuumingcanhelpreduceexposuretoallergens.

2.Nasalsalineirrigation:Salineirrigationcanhelpclearthenasalpassagesofmucusandallergens.Itinvolvesusingasaltwatersolutiontoflushoutthenasalpassages,eitherbyusingasyringe,netipot,orspecializednasalirrigationdevice.

3.Steaminhalation:Inhalingsteamcanhelprelievenasalcongestionandreduceinflammation.Thiscanbedonebytakingahotshowerorusingahumidifier.

4.Dietarymodifications:Certainfoodsmaytriggerallergicreactionsorexacerbatesymptomsofallergicrhinitis.Forexample,somepeoplemaybeallergictodairyorgluten.Aneliminationdietcanhelpidentifywhichfoodsmaybecontributingtosymptoms.

5.Acupuncture:Somestudiessuggestthatacupuncturemaybeeffectiveinreducingsymptomsofallergicrhinitis,althoughmoreresearc

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論